Stemtech Corp (STEK) Form 10-K — May 29, 2026
Stemtech Corp reported a net loss of $4.05 million for the fiscal year ended December 31, 2025, driven by a 43% decline in revenue to $2.88 million due to supply chain disruptions and stock-outs of key products. The auditor issued a going-concern opinion, citing recurring losses, an accumulated deficit of $34.9 million, and a working capital deficiency of approximately $10.4 million. The company disclosed it is in default under certain Merchant Cash Advance financing agreements, raising substantial doubt about its ability to continue operations.
Key figures
- Revenue
- 2876380
- Total Debt
- 4162199
- Cash Position
- 238245
- Shares Outstanding
- 2067960034
- Accumulated Deficit
- 34877757
- Stockholders Deficit
- 7704399
- Working Capital Deficit
- 10396951
- Inventory Financing Secured
- 2500000
- Post Balance Sheet Shares Issued
- 1223835979
AI analysis
Red flags8 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.